Human data interaction through design:An explorative step from theory to practice using design as a vehicle

The increasing use of personal data and AI in everyday technologies has resulted in the amplification of complex and intertwined socio-technical challenges. These, often exemplified by data abuse, breaches, and exploitation, must be alleviated to support sustainable, resilient and human-centred data economies and positive global innovation. Here, we turn towards Human-Data Interaction, an interdisciplinary branch of research, inspired by HCI, that brings together diverse siloed perspectives to present three holistic response principles: data legibility, negotiability and agency. But, the emergent nature of this field calls for refinement of these theoretical tenets to help them translate into practical and tangible responses that are embedded in the technologies we create. We propose this workshop as a foundational step towards this agenda by opening these principles to the CHI community to encourage critique and dialogue about the strengths, weaknesses, value and opportunities of incorporating HDI into the design and evaluation of technology. The outcomes of this workshop, by engaging with HDI through Design, will form the basis for the next stages of research within HDI by contributing to foundational texts within academia and implementing HDI-infused systems within industry

WSES guidelines for management of Clostridium difficile infection in surgical patients

In the last two decades there have been dramatic changes in the epidemiology of Clostridium difficile infection (CDI), with increases in incidence and severity of disease in many countries worldwide. The incidence of CDI has also increased in surgical patients. Optimization of management of C difficile, has therefore become increasingly urgent. An international multidisciplinary panel of experts prepared evidenced-based World Society of Emergency Surgery (WSES) guidelines for management of CDI in surgical patients

WSES guidelines for management of Clostridium difficile infection in surgical patients

In the last two decades there have been dramatic changes in the epidemiology of Clostridium difficile infection (CDI), with increases in incidence and severity of disease in many countries worldwide. The incidence of CDI has also increased in surgical patients. Optimization of management of C difficile, has therefore become increasingly urgent. An international multidisciplinary panel of experts prepared evidenced-based World Society of Emergency Surgery (WSES) guidelines for management of CDI in surgical patients.Peer reviewe

Incidence of surgical rib fixation at chest wall injury society collaborative centers and a guide for expected number of cases (CWIS-CC1)

Purpose: Surgical stabilization of rib fractures (SSRF) improves outcomes in certain patient populations. The Chest Wall Injury Society (CWIS) began a new initiative to recognize centers who epitomize their mission as CWIS Collaborative Centers (CWIS-CC). We sought to describe incidence and epidemiology of SSRF at our institutions. Methods: A retrospective registry evaluation of all patients (age &gt; 15 years) treated at international trauma centers from 1/1/20 to 7/30/2021 was performed. Variables included: age, gender, mechanism of injury, injury severity score, abbreviated injury severity score (AIS), emergency department disposition, length of stay, presence of rib/sternal fractures, and surgical stabilization of rib/sternal fractures. Classification and regression tree analysis (CART) was used for analysis. Results: Data were collected from 9 centers, 26,084 patient encounters. Rib fractures were present in 24% (n = 6294). Overall, 2% of all patients underwent SSRF and 8% of patients with rib fractures underwent SSRF. CART analysis of SSRF by AIS-Chest demonstrated a difference in management by age group. AIS-Chest 3 had an SSRF rate of 3.7, 7.3, and 12.9% based on the age ranges (16–19; 80–110), (20–49; 70–79), and (50–69), respectively (p = 0.003). AIS-Chest &gt; 3 demonstrated an SSRF rate of 9.6, 23.3, and 39.3% for age ranges (16–39; 90–99), (40–49; 80–89), and (50–79), respectively (p = 0.001). Conclusion: Anticipated rate of SSRF can be calculated based on number of rib fractures, AIS-Chest, and age. The disproportionate rate of SSRF in patients age 50–69 with AIS-Chest 3 and age 50–79 with AIS-Chest &gt; 3 should be further investigated, as lower frequency of SSRF in the other age ranges may lead to care inequalities.</p